Loading...

CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC Legal Disputes 8-K Filing

CHRL

CRL

CHARLES RIVER LABORATORIES INTERNATIONAL INC

(CRL)

2025 8-K

Planned Divestitures

Management Change

Financial Results Released

Conference Presentation

Leadership Transition

Investor Conference Update

SEC Investigation Concluded

Financial Results

Management Change

Management Change

Financial Statements

Financial Statements

Share Purchases

Financial Results

Healthcare Conference

Credit Agreement Update

Q3 Financial Results

Earnings Reports

Shareholder Meeting

Earnings Reports

Earnings Reports

Appointment of Director

Management Change

Purchase of Shares

Financial Results for Q3 2023

Financial Results for Q2 2023

Annual Meeting of Shareholders

Earnings Report

Earnings Reports

External Links:

On November 14, 2025, Charles River Laboratories announced that the SEC concluded its investigation into the company regarding non-human primate sourcing and will not recommend enforcement action, with no material findings from the company’s own independent investigation conducted earlier in 2023.

AI Assistant

CHARLES RIVER LABORATORIES INTERNATIONAL INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.